Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis

Title
Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis
Authors
Keywords
Geldanamycin, Hsp90 inhibitor, Paclitaxel, Ovarian cancer, p38/H2AX axis
Journal
TUMOR BIOLOGY
Volume 37, Issue 11, Pages 14745-14755
Publisher
Springer Nature
Online
2016-09-15
DOI
10.1007/s13277-016-5297-2

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started